Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alnylam Pharmaceuticals Inc. (ALNY)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Casdin Capital

Eli Casdin

585,000 $63,677 +14% 6.75%
2.
Slate Path Capital

David Greenspan

718,000 $78,154 -12% 5.99%
3. 735,000 $80,005 4.76%
4.
Bridger Management

Roberto Mignone

347,573 $37,833 -26% 4.37%
5.
Maverick Capital

Lee Ainslie

1,339,705 $145,827 -41% 3.07%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$144.33 5,013 Officer, Director 197,589 2020-05-20 Filing
$143.46 16,315 Officer, Director 202,602 2020-05-20 Filing
$142.51 13,437 Officer, Director 218,917 2020-05-20 Filing
$149.99 22,265 Officer 62,236 2020-05-06 Filing
$150.00 50,000 Officer 4,820 2020-05-06 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,681,645 $183,047 7.87%
2. 1,100,000 $119,735 5.06%
3. 1,775,264 $193,237 3.74%
4. 142,454 $15,506 2.53%
5. 29,000 $3,157 2.06%
News See All